Columbia biomedical engineers are collaborating with orthopedic surgeons to build a living replacement knee to be tested in clinical trials within five years.
Columbia genome engineers are designing a CRISPR-based gene therapy with potential to prevent blindness in anyone with retinitis pigmentosa, a condition caused by more than 80 different genes.
Research to delay aging would have better population health and economic returns than advances in individual fatal diseases such as cancer or heart disease, according to Mailman study.
Deficiency of a protein in the hippocampus is a major cause of age-related memory loss, and this form of memory loss is reversible, according to Columbia researchers.
Ottavio Arancio, MD, PhD, of CUMC's Taub Institute, coauthored a paper on a compound that prevents memory loss in a mouse model of Alzheimer's. See Northwestern's news release: http://bit.ly/14Zqwwn
A thumb-sized hearing aid worn behind the ear and held in place by a small magnet is available at NY-Presbyterian/Columbia to those who cannot wear conventional hearing aids.
African-Americans carrying a variant in a cholesterol-processing gene, ABCA7, have double the risk for Alzheimer’s than non-carriers. A new study led by CUMC's Richard Mayeux; first author Christiane Reitz.